Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621893 · ClinicalTrials.gov registry record
Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions
A clinical trial of Bone Marrow Edema, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 70
- Enrollment target
- 6
- Study locations
NCT01621893 is a study of Bone Marrow Edema that has completed, run by Zimmer Biomet. The registered enrollment target is 70 participants. The trial reports 6 study locations across 5 states.
The verdict
NCT01621893, a study of Bone Marrow Edema, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 6
- Study locations
Study Summary
Studying long-term changes in a sub-set of patients who undergo the Subchondroplasty procedure including changes in pain, function, and overall health.
Conditions Studied
Interventions
- PROCEDURE Subchondroplasty
Study Locations (6)
Pennsylvania
- Rothman Institute - Philadelphia
- Allegheny Orthopaedic Associates - Pittsburgh
California
- CORE Orthopaedics - Encinitas
Illinois
- Hinsdale Orthopedics - New Lenox
New York
- Hospital for Joint Disease - New York
South Carolina
- Steadman Hawkins Foundation - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-03-26 |
| Est. Completion | 2021-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621893
The ClinicalTrials.gov registry entry for NCT01621893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Marrow Edema appearing as the primary indexed condition, and to 1 intervention - of which Subchondroplasty is the first listed.
NCT01621893 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Pennsylvania, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT01621893 about?
NCT01621893 is a clinical study titled "Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions". Studying long-term changes in a sub-set of patients who undergo the Subchondroplasty procedure including changes in pain, function, and overall health.
What is the current status of trial NCT01621893?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-03-26. Estimated completion is 2021-05-26.
What conditions does trial NCT01621893 study?
This clinical trial studies the following conditions: Bone Marrow Edema.
What interventions are being tested in trial NCT01621893?
The interventions under investigation include: Subchondroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT01621893?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01621893 being conducted?
This trial has 6 study locations across California, Illinois, New York, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.